FDA Approves Device to Screen Women With Dense Breasts as Adjunct to Mammography
The device is not intended to be used as a replacement for screening mammography.
Diagnostic Agents
D-Dimer Level Not Useful for Ruling Out PE in COVID-19 Patients
Overall, 92.3% of patients had plasma D-dimer levels ≥0.05 µg/mL, including all with and 91.2% without, pulmonary embolism
Nearly 200,000 COVID-19 Home Tests Recalled Over False Positives
Problem with the rapid antigen tests was caused by variations in the quality of one of the raw materials used in the products
FDA Approves Change in Contraindications for Optison
The removal of the contraindication to screen for hypersensitivity to blood and blood products is expected to improve workflow efficiency for health care professionals.
FDA Clears New Technology for Computed Tomography Imaging
The NAEOTOM Alpha utilizes photon-counting detectors that measure each individual X-ray that passes through a patient’s body to create a detailed 3-dimensional image.
Lack of Regular Albuminuria Screening Leaves CKD Undetected
Despite similar risk for albuminuria with diabetes, albumin-to-creatinine ratio screening in patients with hypertension remains very low
High Demand for At-Home COVID-19 Tests Could Hamper Supply, Abbott Says
Sales have skyrocketed due to the surge in cases driven by the highly transmissible delta variant
Fifteen Headache-Day Threshold Does Not Capture Migraine Burden
Findings raise questions about the current headache frequency used for classification of migraine headaches
Model Predicts False-Positives in Breast Cancer MRI Screen
Full prediction model could prevent 45.5 percent of false-positive recalls, 21.3 percent of benign biopsies for those with extremely dense breasts
Genetic Testing Proposed for Women Diagnosed With Breast Cancer at Age 65+
Mutations in actionable breast cancer risk genes present in 3.2 percent of older women with breast cancer
